Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Thalidomide (THAL) and Lenalidomide (LEN)-Associated Venous Thromboembolism (VTE): Optimal Prophylaxis Strategies Remain Elusive

June M. McKoy, MD, JD, MPH, MBA, Dustin B Liebling, BA, Alfred W. Rademaker, PhD, Bing Bing Weitner, MS, Beatrice J. Edwards, MD, MPH, Steven M. Belknap, MD, Andrew Thurston, MD, Monica Boen, MD, Katrina-Marie E Tulas, BA, Judith M McKoy-Bent, BA, BSN, Jowella Pineda, MD, Dennis P. West, PhD

Blood (2012) 120 (21): 4692.

https://doi.org/10.1182/blood.V120.21.4692.4692

Published: 2012

Journal Articles

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Andrew M. Evens, DO, MSc, Irene Helenowski, MS, Chadi Nabhan, MD, FACP, Erika Ramsdale, MD, June M McKoy, MD, JD, MPH, MBA, Annette Larsen, B.A., R.N., Sarah Miyata, RN, MSN, ACNP, Benjamin Parsons, DO, Reem Karmali, MD, Britt E. Hanson, DO, Leo I. Gordon, MD, FACP, Scott E. Smith, MD, PhD, FACP, Stephanie A. Gregory, MD, Sonali M. Smith, MD

Blood (2011) 118 (21): 2625.

https://doi.org/10.1182/blood.V118.21.2625.2625

Published: 2011

Journal Articles

Multicenter Analysis of 150 Very Elderly Non-Hodgkin's Lymphoma (NHL) Patients: Impact of Comorbidities and Response to Initial Therapy on Survival

Andrew M Evens, DO, MSc, Chadi Nabhan, MD, FACP, Irene Helenowski, PhD, Annette Larsen, B.A., R.N., Erika E. Ramsdale, MD, Reem Karmali, MD, Josephine L. Feliciano, MD, Benjamin Parsons, MD, June M McKoy, MD, JD, MPH, MBA, Stephanie A. Gregory, MD, Sonali M Smith, MD

Blood (2010) 116 (21): 3124.

https://doi.org/10.1182/blood.V116.21.3124.3124

Published: 2010

Journal Articles

Erythropoietin Stimulating Agents (ESAs): Reassessment of Use in Cancer and Chronic Kidney Disease (CKD) Settings in the United States, Canada, and Europe.

Charles L Bennett, MD, PhD, Athena T Samaras, BA, June M McKoy, MD, JD, MPH, Beatrice J Edwards, MD, FACP, Mi Zheng, Matthew J Fisher, BA, Simone N Boyle, BA, Steven M Trifilio, RPh, Monica Boen, BA, Dianne Deleon, BA, Dennis P West, PhD

Blood (2009) 114 (22): 4538.

https://doi.org/10.1182/blood.V114.22.4538.4538

Published: 2009

Journal Articles

From Bench to Bedside: Hematopoietic Growth Factors (HGFs)- a Cause of Serious and Unanticipated Class Toxicities.

Charles L. Bennett, MD, PhD, Ari Polish, MD, Athena T Samaras, BA, Mi Zheng, Dennis P West, PhD, Steven M Trifilio, RPh, Beatrice J Edwards, MD, FACP, Simone N Boyle, BA, Matthew J Fisher, June M McKoy, MD, JD, MPH

Blood (2009) 114 (22): 4555.

https://doi.org/10.1182/blood.V114.22.4555.4555

Published: 2009

Journal Articles

Connecticut Attorney General Blumenthal's Citizen Petition Regarding Thalidomide-Associated VTE Redux: Patient Safety Concerns Still Persist.

June M. McKoy, MD, JD, MPH, Monica Boen, BA, Dianne Deleon, BA, Josephine Feliciano, MD, D. Mark Courtney, MD, Charles L. Bennett, MD, PhD

Blood (2009) 114 (22): 3990.

https://doi.org/10.1182/blood.V114.22.3990.3990

Published: 2009

Journal Articles

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Charles L. Bennett, MD, PhD, MPP, Thanh Ha Luu, BA, Anaadriana Zakarija, MD, Hau C. Kwaan, MD, PhD, Nicholas Bandarenko, MD, Dilip K. Pandey, MBBS, MS, PhD, John F. Cursio, MS, June M. McKoy, MD, JD, MPH, Charlie Buffie, BA, Jeffrey L. Winters, MD, Thomas L. Ortel, MD, Ravindra Sarode, MD, X. Long Zheng, MD, PhD, Thomas J. Raife, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Gail A. Rock, MD, PhD

Blood (2007) 110 (11): 2088.

https://doi.org/10.1182/blood.V110.11.2088.2088

Published: 2007

Journal Articles

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

Elizabeth A. Richey, BA, Charles L. Bennett, MD, PhD, MPP, Hau C. Kwaan, MD, PhD, Anaadriana Zakarija, MD, MSCI, Nicholas Banderanko, MD, Dilip K. Pandey, MD, PhD, June M. McKoy, MD, JD, MPH, Paul R. Yarnold, PhD, Dennis W. Raisch, PhD, Jeffrey L. Winters, MD, Thomas J. Raife, MD, John F. Cursio, MS, Matthew J. Fisher, Thomas L. Ortel, MD, PhD, Martin S. Tallman, MD, Masanori Matsumoto, MD, PhD, Yoshihiro Fujimura, MD, PhD, Joel L. Moake, MD

Blood (2007) 110 (11): 2089.

https://doi.org/10.1182/blood.V110.11.2089.2089

Published: 2007

Journal Articles

RADAR Update on Thalidomide (Thal)- and Lenalidomide (Len)-Associated Venous Thromboembolism (VTE): Safety Concerns Persist for Multiple Myeloma (MM) Despite FDA Approvals in This Setting.

Charles L. Bennett, MD, PhD, MPP, Zehra Hussain, Mark Courtney, MD MPH, Paul Yarnold, PhD, Dennis Raisch, PhD, June M. McKoy, MD JD MPH

Blood (2006) 108 (11): 3310.

https://doi.org/10.1182/blood.V108.11.3310.3310

Published: 2006

Journal Articles

Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies: Are Policy Changes Needed?.

Elizabeth A. Lyons, BA, June M. McKoy, MD, JD, MPH, Steven Belknap, MD, Kenneth R. Carson, MD, Charles L. Bennett, MD, PhD

Blood (2004) 104 (11): 266.

https://doi.org/10.1182/blood.V104.11.266.266

Published: 2004

Journal Articles

Long-Term Follow-Up of 98 Cases of Recombinant Human Erythropoietin (epoetin) Induced Pure Red Cell Aplasia (PRCA): Outcomes and Treatment Data from the Research on Adverse Drug Reactions and Reports (RADAR) Program.

Kenneth R. Carson, MD, Stephen A. Klinge, BA, Steven M. Belknap, MD, June M. McKoy, MD, JD, MPH, Dennis W. Raisch, PhD, Martin S. Tallman, MD, Timothy M. Kuzel, MD, Andrew M. Evans, MD, Benjamin Kim, MD, Paul R. Yarnold, PhD, Elizabeth A. Lyons, BA, Charles L. Bennett, MD, PhD

Blood (2004) 104 (11): 5320.

https://doi.org/10.1182/blood.V104.11.5320.5320

Published: 2004

Journal Articles

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Charles L. Bennett, MD, PhD, Kenneth R. Carson, MD, June M. McKoy, MD, JD, MPH, Steven M. Belknap, MD, Stephen A. Klinge, BA, Andrew M. Evens, MD, Dennis W. Raisch, PhD, Paul R. Yarnold, PhD, Benjamin Kim, MD, Elizabeth A. Lyons, BA, Timothy K. Kuzel, MD, Martin S. Tallman, MD

Blood (2004) 104 (11): 5319.

https://doi.org/10.1182/blood.V104.11.5319.5319

Published: 2004

NARROW

Thalidomide (THAL) and Lenalidomide (LEN)-Associated Venous Thromboembolism (VTE): Optimal Prophylaxis Strategies Remain Elusive

Multicenter Analysis of Elderly Hodgkin Lymphoma (eHL): Outcomes and Prognostic Factors in the Modern Era

Multicenter Analysis of 150 Very Elderly Non-Hodgkin's Lymphoma (NHL) Patients: Impact of Comorbidities and Response to Initial Therapy on Survival

Erythropoietin Stimulating Agents (ESAs): Reassessment of Use in Cancer and Chronic Kidney Disease (CKD) Settings in the United States, Canada, and Europe.

From Bench to Bedside: Hematopoietic Growth Factors (HGFs)- a Cause of Serious and Unanticipated Class Toxicities.

Connecticut Attorney General Blumenthal's Citizen Petition Regarding Thalidomide-Associated VTE Redux: Patient Safety Concerns Still Persist.

Clinical and Outcomes Findings for Thrombotic Thrombocytopenic Purpura among 467 Persons with Severely Versus Not Severely Deficient ADAMTS-13 Levels.

Ticlopidine- and Clopidogrel-Associated Thrombotic Thrombocytopenic Purpura (TTP): Final Results from the Surveillance Epidemiology and Risk Factor-TTP Study Group.

RADAR Update on Thalidomide (Thal)- and Lenalidomide (Len)-Associated Venous Thromboembolism (VTE): Safety Concerns Persist for Multiple Myeloma (MM) Despite FDA Approvals in This Setting.

Accelerated FDA Approval of Drugs Used To Treat Hematologic Malignancies: Are Policy Changes Needed?.

Long-Term Follow-Up of 98 Cases of Recombinant Human Erythropoietin (epoetin) Induced Pure Red Cell Aplasia (PRCA): Outcomes and Treatment Data from the Research on Adverse Drug Reactions and Reports (RADAR) Program.

Long-Term Follow-Up of Recombinant Human Erythropoietin (epoetin)Induced Pure Red Cell Aplasia (PRCA): A Comparison of Data Collected through Active and Passive Pharmacovigilance Efforts.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only